Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

daratumumab 3 Dexamethasone 3 Bortezomib 2 sodium thiosulfate 1 pomalidomide 1 pembrolizumab 1 etoposide phosphate 1 darlin protein, Dictyostelium 1 bosutinib 1 Thalidomide 1 Restraint, Physical 1 Pemetrexed 1 Mitoxantrone 1 Lenalidomide 1 Gemtuzumab 1 Etoposide 1 Daunorubicin 1 Cytarabine 1 Crizotinib 1 Cisplatin 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Has announcements × Thalidomide × Clear all

NCT02541383 2025-04-13

Cassiopeia

Intergroupe Francophone du Myelome

Phase 3 Completed

1,085 enrolled 22 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡